Baker Bros. Advisors LP Forma Therapeutics Holdings, Inc. Transaction History

Baker Bros. Advisors LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$7.12 - $20.24 $983,385 - $2.8 Million	-138,116 Reduced 6.82%	1,886,760 $37.6 Million
Q4 2020 Feb 16, 2021	BUY	$34.9 - $51.08 $8.84 Million - $12.9 Million	253,367 Added 14.3%	2,024,876 $70.7 Million
Q3 2020 Nov 16, 2020	SELL	$32.95 - $50.25 $7.53 Million - $11.5 Million	-228,491 Reduced 11.42%	1,771,509 $88.3 Million
Q2 2020 Aug 14, 2020	BUY	$39.0 - $46.49 $78 Million - $93 Million	2,000,000 New	2,000,000 $93 Million

26.5K

Ticker FMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,860,400
Market Cap $958M
Description
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...

Get notified when there are updates to the investment portfolio of Baker Bros. Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Baker Bros. Advisors LP with notifications on news.